Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Orlova, J. Nikolaeva, L. Kiruchina, A. Speranskaya, V. Perley, A. Gichkin (Saint-Petersburg, Russian Federation). Follow up 1 year of amiodarone pulmonary effects. Eur Respir J 2011; 38: Suppl. 55, 3745

Member's Comments

No comment yet.

Related content which might interest you: Evolution of pulmonary embolism: 1 year of follow-up Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Efficacy of a 12 months oral sildenafil treatment in patients with severe pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 660s Year: 2006 The effectiveness of carrying out 6 month and 1 year re-assessments for respiratory patients post pulmonary rehabilitation Source: Annual Congress 2012 - Physiotherapy and rehabilitation strategies in respiratory diseases and beyond Year: 2012 Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 The effects of an 8 week pulmonary rehabilitation programme in patients with bronchiectasis Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008 Results of a dedicated service for pulmonary embolism (PE): 1 year follow up Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004 The effect of single dose inhaled budesonide on Amppc20 in patients with mild asthma: a 3 month follow up Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005 Follow up of OSA patients after 10 years of diagnosis Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Are the benefits of pulmonary rehabilitation sustained after 6 months? Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 Efficacy of epoprostenol treatment for pulmonary hypertension: hemodynamic and clinical improvement during the initial 8-month period Source: Eur Respir J 2001; 18: Suppl. 33, 325s Year: 2001 Ambrisentan therapy for PAH patients with WHO class II symptoms: one year follow-up. Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Acute effects, 1-year, and 2-year follow up of iloprost-aerosol therapy in severe primary pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001 Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial Source: International Congress 2019 – Management of airway diseases in primary care Year: 2019 Six months and one year follow up of COPD patients who had oral nutritional supplement therapy as a part of pulmonary rehabilitation program Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 One year follow-up on pulmonary function for lobectomized patients. Source: International Congress 2017 – General thoracic surgery Year: 2017 Predictive value of 6 MWD and derived indices 3 months after initial PAH therapy for the necessity of a combination therapy in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Corticosteroids significantly improve symptom score in patients with active pulmonary sarcoidosis over a two year follow up Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011